Preface. I: Subcellular Basis of Heart Failure. 1. Tumor Necrosis Factor Alpha in Chronic Heart Failure; T. Bachetti, et al. 2. Myocardial Ribonuclease Activity in Heart Failure; P. J. O'Brien, et al. 3. Beta-Adrenergic Receptor Mechanisms in Heart Failure; R. Sethi, et al. 4.Vascular alpha-Adrenergic Function in Congestive Heart Failure; Q.P. Feng, J.M.O. Arnold. 5. Altered Myocardial Neurotransmitter and 1,2-Diacylglycerol Concentrations in Right Ventricular Hypertrophy and Failure in Rats; K. Okumura, et al. 6. Metabolic Changes in Non-Ischemic Myocardium During Pump Failure; H. Ishioka, et al. 7. The Cardiac Extracellular Matrix and Its Role in the Development of Heart Failure; H. Ju, I.M.C. Dixon. 8. The SHHF/Mcc-facp Rat Model: A Genetic Model of Congestive Heart Failure; S.A. McCune, et al. 9. Left Ventricular Mass and Diastolic Function in Young Individuals with a First Elevated `Casual' Blood Pressure; S.M. De Lena, et al. 10. Factors Responsible for Left Ventricular Underfilling in Pure Mitral Stenosis; A. Surdacki, et al. 11. Improved Preservation of Myocardial Ultrastructure in Perfusion-Fixed Human Heart Explants; A.M. Gerdes, et al. 12. Involvement of Leukotoxin in Pathogenesis of Patients with Extensive Burns; K. Kosaka, et al. 13. Differential Regulation of Calmodulin-Dependent Cyclic Nucleotide Phosphodiesterase isozymes; R.K. Sharma, et al. II: Pathophysiological Aspects of Cardiomyopathies. 14. Adriamycin Cardiomyopathy and Its Prevention in an Animal Model; N. Siveski-Iliskovic, et al. 15. Alterations in Sacrolemmal Phospholipid Base Exchange Enzymatic Activities in Diabetic Cardiomyopathy; A. Vecchini, et al. 16. Myocardial Lipid Peroxidation and Diabetes; S.K. Jain. 17. Molecular Biological Changes of Adenine Nucleotide Translocator in J-2-N Cardiomyopathic Hamsters; M. Kato, et al. 18. The Renin&endash;Angiotensin System and the Congenital Cardiomyopathic Hamster; C. Lambert, et al. 19. Dietary Mercury Induces Congestive Cardiomyopathy in the Arctic; I. Asmussen. 20. Peripheral Resistance to Atrial Natriuretic Peptide in Patients with Idiopathic Dilated Cardiomyopathy; G. Iervasi, et al. 21. The Effect of Ethanol on Allylamine-Induced Subendocardial Fibrosis; K. Kato, et al. 22. Nitric Oxide: Friend and Foe in Myocardial Ischemia and Reperfusion; R.C. Kukreya. 23. Role of Leukocytes and Subcellular Abnormalities in Diastolic Dysfunction During Ischemia-Reperfusion; J.S. Juggi, et al. 24. Calcium Channel Blockade Ameliorates Cardiac Dysfunction and Failure in Ischemic Cardiomyopathy; J.M. Capasso. 25. Alterations in Autonomic Nervous System and Heart Mitochondrial Function in Rats Treated with Cyclophosphamide; S. Sugiyama, et al. III: Treatment of Heart Failure. 26. Combined Aerobic and Strength Training in CHF Patients: Pilot Project on Safety and Feasibility; R. Gutierrez, et al. 27. Factors Relating to 6 Minute Walk Performance in Heart Failure Patients; M.C. Hendrican, et al. 28. Dynamic Cardiomyoplasty &endash; The Management of Heart Failure Using Autologous Skeletal Muscle; J.N.K. Odim. 29.
